Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

(2011) Chin-Chou Huang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Bisphosphonates: The first 40years

(2011) R. Graham G. Russell   BONE

Alendronate Adherence and Its Impact on Hip-Fracture Risk in Patients With Established Osteoporosis in Taiwan

(2011) T-C Lin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Use of Bisphosphonates and Reduced Risk of Colorectal Cancer

(2011) Gad Rennert et al.   JOURNAL OF CLINICAL ONCOLOGY

Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke

(2011) Chia-Hung Chiang et al.   STROKE

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

(2010) P A Newcomb et al.   BRITISH JOURNAL OF CANCER

Statin use in patients with asthma - a nationwide population-based study

(2010) Chin-Chou Huang et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer

(2010) Chris R. Cardwell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer

(2010) Gad Rennert et al.   JOURNAL OF CLINICAL ONCOLOGY

More on Reports of Esophageal Cancer with Oral Bisphosphonate Use

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Antitumor effects of bisphosphonates: Promising preclinical evidence

(2008) Theresa A. Guise   CANCER TREATMENT REVIEWS